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Production of platform chemicals from renewable feedstocks is becoming increasingly 
important due to concerns on environmental contamination, climate change, and 
depletion of fossil fuels. Adipic acid (AA), 6-aminocaproic acid (6-ACA) and 1,6-
hexamethylenediamine (HMD) are key precursors for nylon synthesis, which are 
currently produced primarily from petroleum-based feedstocks. In recent years, the 
biosynthesis of adipic acid from renewable feedstocks has been demonstrated using both 
bacterial and yeast cells. Here we report the biocatalytic conversion/transformation of AA 
to 6-ACA and HMD by carboxylic acid reductases (CARs) and transaminases (TAs), 
which involves two rounds (cascades) of reduction/amination reactions (AA à 6-ACA 
à HMD). Using purified wild type CARs and TAs supplemented with cofactor 
regenerating systems for ATP, NADPH, and amine donor, we established a one-pot 
enzyme cascade catalyzing up to 95% conversion of AA to 6-ACA. To increase the 
cascade activity for the transformation of 6-ACA to HMD, we determined the crystal 
structure of the CAR substrate-binding domain in complex with AMP and succinate and 
engineered three mutant CARs with enhanced activity against 6-ACA. In combination 
with TAs, the CAR L342E protein showed 50-75% conversion of 6-ACA to HMD. For 
the transformation of AA to HMD (via 6-ACA), the wild type CAR was combined with 
the L342E variant and two different TAs resulting in up to 30% conversion to HMD and 
70% to 6-ACA. Our results highlight the suitability of CARs and TAs for several rounds 
of reduction/amination reactions in one-pot cascade systems and their potential for the 




Polymers and their precursors constitute the largest fraction of all chemical products 
manufactured today. The global polymer market was valued at USD 522.7 billion in 2017 
and is expected to grow at 4.0% annually over 2019-2025 (Grand View Research). The 
fastest growing polymer markets include polyamides and polyesters, with compound 
annual growth (CAGR) up to 8% 1. In addition, worldwide demand for biobased 
polymers is quickly increasing, mostly driven by reduction of carbon footprints, 
switching to renewable feedstocks, and rising consumer awareness concerning 
sustainability issues 1-4. Since the functional groups of polyamide and polyester 
precursors (amino, carboxyl, and hydroxyl) are common to the biological world, their 
total synthesis by biocatalysis or fermentation can be expected to be feasible. The global 
bio-polyamide market was valued at USD 110.5 million in 2016, and is projected to 
increase at a CAGR of 12.9% from 2017 to 2025 (Grand View Research, online report 
2017) 1-2. Nylon-6 and nylon-6,6 account for appr. 90% of the total amount of nylon 
produced today (worldwide nearly 7 million tons annually) 1. Nylon-6 is a homopolymer 
of 6-aminocaproic acid (6-ACA), whereas nylon-6,6 is a co-polymer of two alternating 
building blocks, adipic acid (AA) and 1,6-hexamethylenediamine (HMD) (Figure 1). AA 
and 6-ACA are synthesized using chemical catalysis from benzene (via cyclohexane) and 
caprolactam, respectively, whereas HMD is predominantly produced by Ni-catalyzed 
hydrocyanation of 1,3-butadiene 5-7. Currently, almost all polymer building block 
chemicals are produced using petroleum-based chemical processes, which are inherently 
non-sustainable and have detrimental impacts on the environment 1-4. Thus, there is an 
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increasing global demand to replace petroleum-based chemical processes with bio-based 
chemical production from renewable resources. 
      Bio-based production of AA has been demonstrated using fatty acids, glucose, and 
glycerol as renewable feedstocks in Escherichia coli, yeast, and Thermobifida 
fusca,expressing engineered or natural (T. fusca) biosynthetic pathways 8-17. Depending 
on the pathway and host used, these processes produced from 3 mg/L to 68 g/L of AA 2, 4. 
Biosynthesis of ACA was achieved using E. coli cells expressing the α-ketoacid 
decarboxylase KdcA from Lactococcus lactis and aminotransferase Vfl from Vibrio 
fluvialis, with the ACA titer up to 160 mg/L 2, 18. Although several patents propose 
various non-natural metabolic pathways for HMD biosynthesis 2, bio-based production of 
this commodity chemical from renewable feedstocks has not yet been realized. Thus, 
further efforts are required to establish and improve the bio-based production of 6-ACA 
and HMD. 
      Recently, carboxylic acid reductases (CARs) have emerged as attractive biocatalysts 
for biotransformation of organic acids to various chemicals 19-22. In the presence of ATP 
and NADPH, CARs catalyze the reduction of carboxylic acids to an aldehyde 23. These 
large enzymes (over 1,000 amino acids) have three domains: an N-terminal Adenylation 
(A) domain fused via a PCP-domain (Peptidyl Carrier Protein, a phosphopantetheine 
attachment site) to a C-terminal Reductase (R) domain (Figure S1) 24-25. The recombinant 
CAR from Nocardia iowensis required post-translational activation 
(phosphopantetheinylation) by a phosphopantetheinyl transferase 25.  The CAR A-domain 
catalyzes the initial reaction between ATP and a substrate acid to form an acyl-AMP 
intermediate, which is then attacked by the phosphopantetheine thiol forming a 
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covalently bound acyl-thioester with the release of AMP 25. The acyl-thioester 
phosphopantetheine then swings from the A-domain to the R-domain resulting in the 
reduction of the thioester by NADPH and producing the aldehyde product 23, 25-26. Crystal 
structures of A-PCP and PCP-R di-domains from N. iowensis and Segniliparus rugosus 
revealed large-scale domain motions during the catalysis with two different 
conformations of the active site region (the “on” and “off” states) 27.  
      Purified recombinant CARs have been shown to accept a broad range of substrates 
including aromatic and aliphatic carboxylic acids 28-29. Several successful applications of 
CARs have already been demonstrated for the production of alkanes, aromatic aldehydes, 
and chiral amines 19-20, 29-33. Highly efficient one-pot enzyme cascades for the 
biosynthesis of chiral piperidines and pyrrolidines or for biocatalytic N-alkylation of 
amines have been developed using CAR, transaminase (TA), imine reductase, and 
reductive aminase biocatalysts 34-36. TAs are pyridoxal-5´-phosphate (PLP) dependent 
enzymes that belong to the PLP fold types I (S-selective) and IV (R-selective) 37-39. These 
enzymes catalyze the transfer of an amino group between an amine donor (different 
amino acids and amines) and an amine acceptor (a ketone or aldehyde). Of particular 
interest are ω-transaminases (ωTAs) which do not require the presence of a carboxylic 
group in substrates and can accept a large variety of carbonyl substrates 39. Over the past 
decade, TAs have attracted considerable interest in biocatalysis both as individual 
biocatalysts and as part of multienzyme cascades for the synthesis of various amines 38-41. 
      In our recent work, we identified several bacterial CARs with robust activity toward 
both aromatic and aliphatic substrates 42. Substrate screening of purified CARs against a 
panel of monocarboxylic acids revealed that these enzymes showed significant reductase 
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activity against C3-C10 substrates with the maximal activity toward C5-C7 substrates 42. 
In addition, the subgroup II CARs, MAB4714 from Mycobacterium abscessus and 
MCH22995 from M. chelonae, exhibited significant activity against AA (C6), 7-
aminoheptanoic acid (C7), and 8-aminooctanoic acid (C8), suggesting that some CARs 
can tolerate the presence of the second charged group in substrates. Purified CARs 
supplemented with cofactor regenerating systems (for ATP and NADPH) and an aldo-
keto reductase (AKR) catalyzed up to 76% conversion of AA to 1,6-hexanediol (Figure 
1) 42. Here we explored the biotransformation of AA to 6-ACA (Cascade-1) and then to 
HMD (Cascade-2) using CARs and ωTAs (Figure 1). When supplemented with cofactor 
regenerating systems, the wild type CAR and ωTA demonstrated up to 95% substrate 
conversion in the in vitro transformation of AA to 6-ACA (Cascade-1) but showed low 
activity in the bioconversion of 6-ACA to HMD (Cascade-2). To enhance CAR activity 
toward 6-ACA, the crystal structure of its substrate-binding domain was determined in 
complex with AMP and succinate and used for structure-based protein engineering. Three 
mutant variants were found to exhibit enhanced activity against 6-ACA, as well as toward 
7-aminoheptanoic acid and 8-aminooctanoic acid. In combination with ωTAs, the CAR 
L342E mutant protein showed up to 80% conversion of 6-ACA to HMD (Cascade-2). 
With AA as substrate, the mixture of the CAR wild type and L342E proteins and two 
ωTAs demonstrated up to 30% conversion to HMD and 70% to 6-ACA. 
 
MATERIALS AND METHODS 
      Gene cloning and protein purification. The genes encoding CARs (MAB4714 and 
MCH22995), TAs, and other enzymes used in this work (Table S1) were amplified by 
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PCR using corresponding genomic DNA and cloned into a modified p15TVLic vector 
(Novagen) containing an N-terminal 6His-tag as described previously 43. The E. coli 
inorganic pyrophosphatase PPA was expressed and purified using a clone from the E. coli 
ASKA collection 44. The phosphopantetheinyl transferase (PPT) BSU03570 (Sfp) from 
Bacillus subtilis was cloned into a pCDFDuet plasmid without a 6His-tag for co-
expression with CARs. Site-directed mutagenesis of the Mycobacterium abscessus CAR 
(MAB4714) and formate dehydrogenase (FDH) from Pseudomonas sp. strain 101 were 
performed using the QuikChange™ site-directed mutagenesis kit (Stratagene) according 
to the manufacturer's protocol, and the mutations were verified by DNA sequencing.  All 
plasmids were transformed into the E. coli BL21(DE3) Gold strain (Agilent). Cells were 
grown in 1 L TB cultures, induced with 0.4 mM IPTG overnight at 16°C (or at 26oC for 
CARs). Recombinant proteins were purified to near homogeneity (>95%, Figure S2) 
using Ni-chelate affinity chromatography on Ni-NTA Superflow resin (Qiagen) as 
described previously 45. The multiple sequence alignment was prepared using the 
MAFFT online tool and STRAP web server 46-47. 
      Enzymatic assays. Carboxylate reductase activity against different carboxylic acids 
was determined spectrophotometrically using an NADPH oxidation-based assay by 
following the decrease in absorbance at 340 nm. CAR assays were performed in a 
reaction mixture (0.2 ml) containing HEPES-K (100 mM, pH 7.5), 1 mM NADPH, 
2.5 mM ATP, 10 mM MgCl2, substrates (10 mM of aliphatic acids and 2 mM of cinnamic 
or benzoic acids), and 5-10 µg of purified CAR. Transaminase activity was determined in 
coupled reaction with alanine dehydrogenase (Ala-DH) BSU31930 or glutamate 
dehydrogenase (Glu-DH) GDH1 spectrophotometrically using an NAD(P)H oxidation-
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based assay by following the decrease in absorbance at 340 nm (adapted from Wilding et 
al.48). Transaminase screens were carried out in a reaction mixture (0.2 ml) containing 
100 mM HEPES-K (pH 7.5), 0.5 mM NADPH or NADH, 1 mM adipaldehyde, 0.05 mM 
PLP, 50 mM NH4Cl, 2 mM Ala, 2 mM Glu, 5 µg of purified aminotransferases, 2.5 µg of 
Ala-DH, and 2.5 µg of Glu-DH. To determine kinetic parameters of enzymes (Km 
and kcat), microplate-based assays were performed (in triplicate) using a SpectraMax M2 
plate-reader in a reaction mixture containing a range of variable substrates at 30°C. 
Kinetic parameters were determined by non-linear curve fitting from Michaelis-Menten 
plots using GraphPad Prism (version 5.00 for Windows, GraphPad Software, San Diego, 
CA). 
      Identification of reaction products. The reaction products of bioconversion 
reactions catalyzed by CARs and TAs (6-ACA and HMD) were quantified on a Varian 
ProStar HPLC system equipped with a fluorescence detector and C18 column (Pursuit 5 
150×3.9 mm; Agilent Technologies, USA) using a modified protocol described 
previously 49. After filtering through 10 kDa spin filters (PES membrane, VWR), 20 µl of 
reaction mixture was mixed with 5 µl of 0.3 M EDTA/0.44 M NaOH and 20 µl 0.5 M 
NaOH (for pH adjustment). For product derivatization, freshly prepared ortho-
phthalaldehyde (OPA) (100 µl of 38.5 mM stock dissolved in 25% methanol (v/v), 10 
mM Na2SO3, and 0.2% formaldehyde (v/v)) was added to 25 µl of reaction mixture (after 
pH adjustment), incubated for 1 min at 37oC (1,000 rpm), and centrifuged for 1 min at 
13,000 rpm (Microfuge 22R Centrifuge, Beckman Coulter, USA). 20 µl aliquots of 
derivatized reaction mixture were injected immediately into the column, and products 
were resolved using the following elution gradient: 0–27 min: 30% solvent A, 70% 
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solvent B; 27–28 min: 0% A, 100% B; 28–30 min: 0% A, 100% B, followed by column 
equilibration  with 80% solvent A, 20% solvent B. Solvent A was 
methanol:acetonitrile:water mix (45:45:10 ratio), and solvent B: 40 mM disodium 
perphosphate (Na2HPO5), 0.01% NaN3 (pH 7.0, flow rate 0.7 ml min−1, 26°C, detection 
wavelength: 340 nm excitation and 455 nm emission) (representative HPLC 
chromatograms are shown in Figure S3).  Product concentrations were determined using 
linear regression analysis of peak areas. Calibration curves were prepared using different 
concentrations of 6-ACA and HMD. Results presented are means ± SEM (standard error 
of mean) from at least three independent determinations.  
      Liquid chromatography-mass spectrometry (LC-MS) analysis of reaction products (6-
ACA and HMD) was performed using a Dionex Ultimate 3000 UHPLC system and a Q-
Exactive mass spectrometer equipped with a HESI-II probe (all from Thermo Scientific) 
and controlled by Thermo XCalibur 4.1 software. LC separation was conducted on a 
Hypersil Gold C18 column (50 mm × 2.1 mm, 1.9 µm particle size, Thermo Scientific) 
equipped with a guard column, column temperature 40°C. Solvent A was 0.1% formic 
acid (in water), solvent B was 0.1% formic acid in methanol (flow rate 0.2 ml/min). 
Autosampler temperature was maintained at 8°C, and injection volume was 10 µl. The 
gradient was 0–1.5 min: 100% A; 1.5–7.0 min: 0% A, 100% B; 10–11 min: 100% A, 0% 
B; 11.0–15.0 min: 100% A. Data collection was done in positive ionization mode with a 
scan range m/z 90–200, resolution 140 000 at 1 Hz, AGC target of 3e6 ions and a 
maximum injection time of 250 ms. Standard solutions of HMD (m/z 117.1386) and 6-
ACA (m/z 132.1019) were used for validation of retention time and m/z. 
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      In vitro biotransformation of carboxylic acids by CARs and ωTAs. In vitro 
biotransformations using MAB4714 and ωTAs (SAV2585 and/or PatA) in the presence 
of cofactor regenerating systems were performed in reaction mixtures (0.2 ml) containing 
100 mM HEPES-K buffer (pH 7.5), 10 mM substrate (AA or 6-ACA), 2 mM NADPH, 2 
mM L-Glu, 2 mM ATP, 5 mM polyP, 10 mM MgCl2, 0.05mM PLP, 100 mM Na-formate, 
50 mM NH4Cl, 20 µg of CHU0107 (PPK2), 20 µg of the FDH D222Q/H224N double 
mutant protein, 20 µg of the E. coli inorganic pyrophosphatase (PPA), 20 µg of Glu-DH, 
80 µg of CAR, and 20 µg of purified aminotransferases PatA or SAV2585 (overnight 
incubation at 30°C, 1,000 rpm). The E. coli inorganic pyrophosphatase PPA was added to 
the reaction to prevent inhibition of CAR activity by pyrophosphate produced during the 
CAR reaction 42, 50. For reactions with Ala-dependent aminotransferases (RHA07987, 
SM5064, and SPO3471), the wild-type FDH (20 µg) and NADH (2 mM) were used in 
the reaction. After 12 h incubation, the reaction mixtures were filtered through 10 kDa 
centrifugation filters (PES membrane, VWR), and the reaction products were analyzed 
using HPLC or LC-MS.  
      Protein Crystallization and Crystal Structure Determination. 16 A domain 
fragments of 11 CARs (636-661 aa) were cloned into a pMCSG53 vector and expressed 
in E. coli BL21(DE3)-Gold cells as 6His-tagged proteins with a TEV cleavage site. 12 
clones were found to produce soluble proteins, from which five proteins were purified for 
crystallization using metal-chelate affinity chromatography as described previously 42. 
The crystals of the MCH22995 A domain (1-641 aa) were obtained by co-crystallization 
and the sitting drop method using 20 mg/mL protein, 2.5 mM adipic acid, 1 mM AMP-
PNP and the reservoir solution 1.5 M lithium sulfate and 0.1 M Tris-HCl (pH 8.5).  
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Crystals were cryo-protected using 25% (w/v) ethylene glycol prior to flash freezing in a 
nitrogen stream.  X-ray diffraction data were collected using a home source Rigaku HF-
007 rotating anode and Rigaku R-AXIS IV detector.  Diffraction data were reduced using 
HKL-3000 51. The structure was solved by Molecular Replacement (MR) using 
Phenix.phaser 52, and the MCH22995 A domain model was built using Phyre2 53 and the 
structure of the A domain of the Nocardia iowensis carboxylate reductase (PDB 5MSD) 
27. The model was rebuilt using Phenix.autobuild, followed by manual model building 
and refinement with Coot 54 and Phenix.refine.  AMP and succinate were built into 
residual Fo-Fc density in the active site of the enzyme after completion of protein model 
building. B-factors were refined and TLS parameterization was included in final rounds 
of refinement. Geometry was verified using Phenix and the wwPDB server. To generate 
the energy-minimized models of the MCH22995 A domain mutants (L345E, G421E, and 
A429W), these mutants were made in Coot and a sphere of 8 Å around succinate was 
energy minimized using YASARA (and default parameters). The crystal structure of the 
MCH22995 A-domain was deposited to the Protein Databank with accession number 
6OZ1 (Table S2). Nucleotide sequences of plasmids used for protein over-expression and 
purification are presented in Table S3.  
 
RESULTS AND DISCUSSION 
      Screening of purified ωTAs with adipaldehyde as substrate. The proposed 
bioconversion of adipic acid (AA) to 6-aminocaproic acid (6-ACA) and 1,6-
hexamethylenediamine (HMD) using carboxylic acid reductases (CARs) and ω-
transaminases (ωTAs) includes two cascades (AA à 6-ACA à HMD) producing several 
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aldehyde intermediates (adipic semialdehyde, adipaldehyde, and 6-aminohexanal), which 
serve as substrates for transaminases (Figure 1). Since adipic semialdehyde is not 
commercially available, we used adipaldehyde as a substrate to screen purified ωTAs for 
amination activity (Figure 1). For this screening, we selected 26 bacterial ωTAs from the 
Pfam families PF00202 (class III) and PF00155 (classes I and II), which were found to be 
expressed as soluble proteins in E. coli (Table S1). Purified proteins were screened for 
adipaldehyde amination activity using an enzyme-coupled NAD(P)H-oxidation assay 
with Glu-DH, Ala-DH and a mixture of L-Glu and L-Ala as amine donors. Significant 
adipaldehyde amination activity was observed in several enzymes including SM5064 
from Sinorhizobium meliloti, SPO3471 from Ruegeria pomeroyi, SAV2585 from 
Streptomyces avermitilis, and E. coli GabT and PatA (Figure S4). Further biochemical 
characterization of the six most active enzymes with adipaldehyde revealed that they can 
use L-Glu (GabT, PatA, and SAV2585) or L-Ala (RHA07987, SM5064, and SPO3471) 
as amine donors with Km for adipaldehyde in the range 0.1 – 1.3 mM and kcat = 0.1 – 1.2 
s-1 (Table 1). Thus, we identified several transaminases active toward adipaldehyde, 
which can be used in combination with CARs for biotransformation of adipic acid to 6-
ACA and HMD.  
      Cofactor regenerating systems for bioconversion of adipic acid using CARs and 
ωTAs. CARs and ωTAs consume ATP, NADPH, and amine donor (L-Ala or L-Glu) 
during biotransformation of adipic acid to 6-ACA and HMD (Figure 2). A common 
strategy to reduce the high costs of cofactor-driven in vitro biotransformations is the use 
of cofactor regenerating systems 55-57. Recently, we established a polyphosphate-based 
regenerating system for the regeneration of ATP from AMP 42. This system is based on 
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the activity of the family-2 polyphosphate kinase (PPK2) CHU0107 from Cytophaga 
hutchinsonii, which catalyzes polyphosphate (polyP)-dependent phosphorylation of AMP 
to ATP (via ADP) and exhibits high activity and affinity to AMP, ADP, and polyP 58. For 
the regeneration of pyridine nucleotides (NADP+ and NAD+), several enzymatic reactions 
have been proposed including phosphite dehydrogenase, glucose-6-phosphate 
dehydrogenase, glucose dehydrogenase, and formate dehydrogenase 55-57. For NADH 
regeneration in this work, we selected the wild type formate dehydrogenase (FDH) from 
Pseudomonas sp. strain 101 (Uniprot ID P33160), which preferentially reduces NAD+ to 
NADH using formate as reductant and producing CO2 59. For NADPH regeneration, we 
introduced two mutations into FDH (D222Q and H224N) producing a mutant FDH 
enzyme (D222Q/H224N) with a preference to NADP+ 42. Finally, the CAR-based 
reactions were supplemented with purified inorganic pyrophosphatase PPA from E. coli 
to prevent activity inhibition by pyrophosphate produced by CAR from ATP 21, 31, 50. In 
our previous work, PPA addition was found to be beneficial for the CAR-based 
transformation of AA to 1,6-hexanediol 42.   
      Adipaldehyde aminotransferases identified in this work use L-Ala or L-Glu as amine 
donors and produce pyruvate or α-ketoglutarate as products (Table 1). For Ala-dependent 
ωTAs, a cyclic cascade reaction has been proposed, which recycles the produced 
pyruvate back into L-Ala using an alanine dehydrogenase (Ala-DH) in the presence of 
ammonia 40, 60-63. The NADH required for activity of Ala-DH can be generated using well 
established NADH-regenerating systems, e,g. a formate/formate dehydrogenase (FDH) or 
glucose/glucose dehydrogenase 40. The feasibility of Ala recycling using Ala-DH has 
been demonstrated for several ω-transaminases catalyzing asymmetric amination of 
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different ketones 64-65. For Glu-dependent ωTAs, the produced α-ketoglutarate can be 
recycled back into L-Glu using ammonia and a glutamate dehydrogenase (Glu-DH). For 
transaminase product recycling in our work, we selected the well characterized NADH-
dependent Ala-DH BSU3188 from Bacillus subtilis (Uniprot Q08352) and NADPH 
dependent Glu-DH GDH1 from S. cerevisiae (P07262) 66-67 (Table S1). For NADPH 
regeneration, both cyclic cascades were supplemented with the FDH D222Q/H224N 
double mutant protein, whereas NADH was regenerated using the wild type FDH (Figure 
2).  
      Biotransformation of AA using the wild type CAR+ωTA cascade with cofactor 
regenerating systems. Without cofactor regenerating systems, the selected ωTAs 
showed 7 ± 3% conversion of AA to 6-ACA when combined with the wild type CAR 
MAB4714 in the presence of ATP, NADPH, and amine donor (Figure S5A, data shown 
for SAV2585). With regenerating systems for ATP, NAD(P)H, and amine donor, these 
enzymes achieved 40% conversion, whereas the addition of the E. coli pyrophosphatase 
PPA increased 6-ACA production to 90-95% conversion (Figure S5A). Similar 
conversion rates to 6-ACA were observed with the five tested ωTAs, but only the 
MAB4714+SAV2585 cascade produced some HMD (1.5-5% conversion) (Figures 3, 
S5). Therefore, SAV2585 was selected for further studies on AA transformation to 6-
ACA and HMD using CARs and ωTAs. The formation of 6-ACA and HMD in reactions 
with CAR+ωTA cascades was confirmed using LC-MS (Figure S6). The low production 
of HMD (Figure 3) and low activity of wild type CARs toward 6-ACA observed in our 
previous work 42 suggest that the presence of a terminal amino group in substrates has an 
adverse effect on binding/activity of wild type enzymes. Therefore, we proposed that the 
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reactivity of CARs toward 6-ACA and other aminated substrates could be enhanced using 
structure-based protein engineering.  
      Another potential bottleneck in the transformation of AA to HMD might be 
associated with the low activity of SAV2585 toward aminated intermediates (e.g. 6-
aminohexanal). We proposed that putrescine transaminases might exhibit higher 
aminotransferase activity toward substrates containing terminal amines. A recent report 
indicated that putrescine TAs represent appealing biocatalysts for biotransformations 
involving diamines 68. The E. coli putrescine TA PatA belongs to aminotransferase class 
III (Pfam PF00202) and catalyzes the transfer of an amino group from terminal diamine 
donor molecules (putrescine, cadaverine) to keto acid acceptors (α-ketoglutarate) 69. The 
Km values for putrescine and α-ketoglutarate were found to be 9.2 mM and 19 mM, 
respectively 69. In pyruvate amination reactions, E. coli PatA showed a preference for C4-
C6 diaminoalkanes as amine donors 68. Recently, E. coli PatA and two other putrescine 
TAs have been shown to exhibit broad specificity for terminal aliphatic diamines making 
them attractive biocatalysts. It was also noted that ωTAs, which can accept amines or 
substrates with an amino group distant from carbonyl, are of special interest for 
biocatalytic applications 40.  
      In our work, we observed that purified E. coli PatA was also active in HMD 
deamination with Km 7.7 mM and kcat 0.4 s-1 (kcat/Km 0.6 × 101). As shown in Table 1, 
PatA exhibited lower activity in the transamination reaction with adipaldehyde as 
acceptor (with L-glutamate as nitrogen donor), but its Km for adipaldehyde was almost 
two orders of magnitude lower (0.1 mM) compared to that for HMD (7.7 mM). Since 
PatA is likely to be tolerant to the presence of amino groups in substrates, we tested this 
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enzyme as an additional ωTA in AA transformation using the MAB4714+SAV2585 
cascade. Indeed, PatA addition stimulated HMD production both from AA and 6-ACA by 
the wild type MAB4714 and SAV2585 (Figure 3).  
      Crystal structure of the CAR A-domain in complex with AMP and succinate. 
Recent biochemical and structural studies of CARs indicated that A-domains of these 
enzymes play a major role in substrate recognition 21, 27, 70. To obtain crystal structures of 
CAR A-domains for structure-based protein engineering studies, we cloned 16 A-domain 
fragments from 11 different CARs from our previous work 42 and purified four A-
domains for crystallization (including MAB4714 and MCH22995 from M. chelonae, 88 
% sequence identity, Figure S1). The MCH22995 A-domain (1-641 aa) produced 
diffracting crystals, and its crystal structure was determined to a resolution of 1.97 Å 
using molecular replacement and the structure of the N. iowensis CAR A-domain (PDB 
code 5MSD) as the model (Table S2). 
      The overall structure of the MCH22995 A-domain revealed the prototypic fold of 
adenylation domains for CARs (N. iowensis and S. rugosus) and acyl-CoA synthetases 
from the ANL superfamily (Figure 4A). The MCH22995 A-domain contains two 
subdomains, an N-terminal subdomain (residues 1-517) and a smaller C-terminal 
subdomain (residues 518-641) (Figure 4). The structure of the N-terminal subdomain 
shows a distorted six-stranded antiparallel β-barrel together with two predominantly 
parallel β-sheets flanked by α-helices, whereas the C-terminal subdomain is made of five 
β-strands surrounded by five α-helices (Figure 4). The MCH22995 active site is located 
at the interface between two subdomains as indicated by the bound AMP and succinate, 
which was presumably carried over through purification from E. coli cells (Figure 4). 
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      Most of the MCH22995 residues interacting with AMP and succinate were from the 
N-terminal subdomain, whereas the conserved Lys621 from the C-terminal domain 
contributed to binding of the nucleotide phosphate (3.2 Å) and ribofuranose oxygen (3.3 
Å) (Figure 5). The adenine base is bound in the anti configuration in the deep cleft 
between the side chains of Tyr422 (3.7 Å) and Tyr510 (4.0 Å), whereas the phosphate 
moiety was coordinated by the main chain groups of the P-loop (Ser262-Thr267) and 
Gly423-Thr425 strand (β16-β17, 3.8 Å). The exocyclic N6-amino group of adenine is 
hydrogen-bonded to the side chain of conserved Asp420 (2.7 Å), while the side chain of 
conserved Asp498 forms hydrogen bonds with the 2´ and 3´ ribose hydroxyls (2.5 and 2.7 
Å). The ATP-binding channel is adjacent to the acid binding pocket as indicated by the 
position of the bound succinate (3.1 Å to the AMP phosphate group). The side chain of 
the conserved His304 is positioned close to the AMP phosphate (3.3 Å) and succinate C4 
carboxyl (4.2 Å), likely coordinating both ATP and acid substrate for an adenylation 
reaction initiated by nucleophilic attack of the acid carboxyl on the ATP α-phosphate. 
      Substrate binding pocket of MCH22995 and rational protein engineering. The 
relatively narrow acid binding pocket of MCH22995 is separated from the ATP binding 
channel by the β15-α15 loop (Ser397-Pro404) and is also defined/bounded by the side 
chains and main chain groups of α11, β16, and α10-β12 strand (Figure 5). It is lined 
mostly by hydrophobic amino acids (Trp286, Leu287, Leu305, Ala306, Leu309, and 
Leu345) and includes several glycine residues (Gly396, Gly398, Gly421, and Gly423) 
(Figure 5). The side chain of Leu345 is positioned above the succinate C1 carboxyl (3.3-
4.3 Å), which is likely close to the position of the adipic acid carboxyl bound in the 
active site (Figure 5). We hypothesized that binding of 6-ACA in the active site of CARs 
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(and consequently their activity toward this substrate) can be enhanced by the 
introduction of residues forming additional interactions with the 6-ACA amino group 
(e.g. salt bridges or hydrogen bonds). Based on the MCH22995 A-domain structure and 
CAR sequence alignment (Figure S1), we selected 10 residues from the acid binding 
pocket of MAB4714 (88 % sequence identity to MCH22995). The targeted residues were 
Leu342 (Leu345 in MCH22995), as well as several Gly or small residues, which were 
mutated to Glu, Gln, or hydrophobic residues (Trp, Phe, or Leu) using site-directed 
mutagenesis.  
      Overall, 16 MAB4714 mutant proteins were purified, and their reductase activities 
were compared with the wild type protein using screening with seven different substrates 
(Figure 5E). With benzoic acid as substrate, most mutant proteins retained significant or 
wild type activity, except for two Gly420 mutant proteins (G420E and Gly420W), which 
were also inactive with most of the tested substrates (Figure 5E). In the MCH22995 
active site, the homologous Gly423 residue is located at the bottom of the acid-binding 
site, near the ATP binding channel, suggesting that the introduction of a large side chain 
at this position will prevent substrate binding.  
      Reductase activity of the MAB4714 mutant proteins toward AA was more sensitive 
to mutations with wild type activity observed in three proteins (A303E, L342F, and 
L342Q) and reduced activity in other mutant proteins (Figure 5E). Notably, enhanced 
reductase activity against 6-ACA was observed in four mutant proteins including L342E, 
L342Q, G418E, and G426W, which also retained significant activity toward AA (Figure 
5E). However, the L342F mutant protein showed no activity increase toward 6-ACA, 
suggesting that binding of this substrate in the MAB4714 active site is facilitated by ionic 
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and/or hydrogen bond interactions (provided by Glu or Gln). The results of substrate 
screening were confirmed by the analysis of kinetic parameters of purified mutant 
proteins, which exhibited higher catalytic rates (kcat) and catalytic efficiencies (kcat/Km) 
with 6-ACA compared to the wild type protein, while retaining wild type or reduced 
levels for AA (Table 2). In particular, the L342E protein showed lower Km and higher kcat 
with 6-ACA compared to wild type MAB4714, resulting in a 10 times higher catalytic 
efficiency (Table 2). As presented in Figure 5, the MAB4714 mutations L342E (Leu345 
in MCH22995), G418E (G421 in MCH22995), and G426W (Gly429 in MCH22995) can 
create additional interactions for binding of 6-ACA in the active site. These mutations 
also greatly enhanced MAB4714 activity toward 7-aminoheptanoic acid and 8-
aminooctanoic acid (Figure 5E, Table 2). Specifically, G426W was up to two orders of 
magnitude more efficient than wild type MAB4714 against these substrates. 
   In vitro biotransformation of 6-ACA and AA using the MAB4714 L342E protein. 
Based on kinetic parameters (Table 2), the MAB4714 L342E mutant protein was selected 
for further studies on AA biotransformation using the CAR+TA cascades. With 6-ACA 
as substrate, purified L342E and SAV2585 showed up to 50% conversion to HMD 
compared to 1.5% observed for wild type MAB4714 (Figures 3 and 6). Furthermore, the 
addition of PatA increased the conversion of 6-ACA to HMD to 70% (Figure 6). As 
expected, adding wild type MAB4714 to L342E produced no improvement in 6-ACA 
transformation for reactions containing one or two TAs (due to low activity of wild type 
protein against 6-ACA). With AA as substrate, the L342E+SAV2585 cascade produced 
small amounts of both 6-ACA and HMD, and the addition of PatA had a minor positive 
effect, suggesting that transformation is limited by the low activity of L342E toward AA 
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(Figure 6). Based on these results, we hypothesized that the conversion of AA to HMD 
can be improved using a combination of the MAB4714 wild type and L342E proteins, 
because the wild type enzyme is more active against AA (CAR1 in Cascade-1), whereas 
the L342E protein is more efficient toward 6-ACA (CAR2 in Cascade-2). Similarly, the 
inclusion of PatA might also be beneficial, since this enzyme appears to improve HMD 
formation from 6-ACA (TA2 Cascade-2) (Figures 3 and 6). Accordingly, when both the 
wild type and L342E proteins were used in combination with one or two TAs for AA 
transformation, the reactions resulted in 30% conversion to HMD (and 60-70% to 6-
ACA) representing a two times improvement compared to the wild type MAB4714 alone 
(Figures 3 and 6). 
 
CONCLUSIONS 
The biocatalytic transformation of terminal diacids (adipic acid) to terminal diamines 
(HMD) using CARs and ωTAs represents a formidable challenge due to the necessity to 
accommodate substrates with different terminal groups (carboxyl, carbonyl, amine) in 
substrate binding sites. Here we demonstrated that purified wild type MAB4714 and 
SAV2585 catalyze efficient transformation of AA to 6-ACA with up to 95% conversion 
but showed low activity in the second round of reduction/amination reactions (6-ACA à 
HMD). Using structure-based protein engineering, we generated three mutant variants of 
MAB4714 (L342E, G418E, G426W) with enhanced activity toward 6-ACA, as well as 
against 7-aminoheptanoic acid and 8-aminooctanoic acid. In combination with SAV2585 
and putrescine transaminase PatA, the L342E variant showed up to 75% conversion of 6-
ACA to HMD but exhibited low activity against AA (the Cascade-1). Therefore, for one-
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pot transformation of AA to HMD (via 6-ACA, Cascades 1 and 2, Figure 1), the wild 
type MAB4714 and SAV2585 were supplemented with the MAB4714 L342E variant and 
putrescine transaminase PatA, resulting in a complete conversion of AA to HMD (30%) 
and 6-ACA (70%). We propose that HMD production from AA can be further improved 
by combining the identified beneficial mutations of MAB4714 (L342E, G418E, and 
G426W) and potentially via protein engineering of TAs. Thus, our study provided 
insights into the molecular mechanisms of substrate selectivity of CARs and illustrated 
the suitability of CARs and ωTAs for two rounds of substrate reduction/amination in one-
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1. GabT (Glu) 0.57 ± 0.07 1.19 ± 0.06	 1.98 ± 0.21 × 103 
2. PatA (Glu) 0.10 ± 0.02	 0.06 ± 0.01	 0.70 ± 0.20 × 103	
3. RHA07987 (Ala) 0.99 ± 0.28	 0.47 ± 0.05	 0.45 ± 0.11 × 103	
4. SAV2585 (Glu) 0.29 ± 0.03	 0.46 ± 0.10	 1.55 ± 0.69 × 103	
5. SM5064 (Ala) 0.09 ± 0.03	 0.44 ± 0.04	 5.41 ± 0.89 × 103	
6. SPO3471 (Ala) 1.27 ± 0.10	 0.71 ± 0.13	 0.66 ± 0.20 × 103	
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Table 2. Kinetic parameters of purified wild type and mutant MAB4714 proteins with 
different substrates. 






benzoic acid wild type 0.6 ± 0.1 8.60 ± 0.15 1.46 ± 0.04 × 104 
L342E 4.3 ± 0.6 3.04 ± 0.25 6.49 ± 1.16 × 102 
G418E 2.3 ± 0.5 5.04 ± 0.50 1.97 ± 0.44 × 103 
G426W 1.0 ± 0.2 3.48 ± 0.43 3.05 ± 0.86 × 103 
adipic acid wild type 23.5 ± 2.8 2.16 ± 0.07 8.89 ± 0.60 × 101 
L342E 56.6 ± 5.0 2.72 ± 0.09 4.65 ± 0.31 × 101 
G418E 18.7 ± 2.5 4.25 ± 0.26 2.03 ± 0.28 × 102 
G426W 24.4 ± 2.8 1.94 ± 0.07 7.66 ± 0.58 × 101 
6-ACA wild type 183.3 ± 28.7 0.77 ± 0.07 3.83 ± 0.76 
L342E 70.1 ± 14.5 2.60 ± 0.22 3.50 ± 0.63 × 101 
G418E 490.9 ± 44.2 3.26 ± 0.12 6.41 ± 0.48 
G426W 189.1 ± 42.7 2.31 ± 0.31 1.06 ± 0.33 × 101 
7-AHAa wild type 315.6 ± 58.2 0.44 ± 0.04 1.27 ± 0.25 
L342E 10.2 ± 1.1 0.64 ± 0.02 6.08 ± 0.39 × 101 
G418E 78.3 ± 11.9 1.02 ± 0.07 1.21 ± 0.18 × 101 
G426W 38.9 ± 6.1 5.12 ± 0.29 1.24 ± 0.15 × 102 
8-AOAb wild type 34.0 ± 2.5 2.62 ± 0.02 7.65 ± 0.11 × 101 
L342E 6.6 ± 1.0 5.28 ± 0.33 7.50 ± 1.00 × 102 
G418E 53.9 ± 6.0 2.57 ± 0.09 4.60 ± 0.34 × 101 
G426W 40.4 ± 6.6 12.3 ± 0.72 2.87 ±0.35 × 102 
a 7-AHA, 7-aminoheptanoic acid. 








Figure 1. Biochemical reactions for the bioconversion of adipic acid using CARs and 
other enzymes. Biotransformations of adipic acid to 6-hydroxyhexanoic acid and 1,6-
hexanediol using CARs and aldo-keto reductases (AKR) have been demonstrated in our 
previous work 42. In this study, we propose using CARs and transaminases (TA) for the 
bioconversion of adipic acid (AA) to 6-aminocaproic acid (6-ACA) (Cascade-1) and then 
to 1,6-hexamethylenediamine (HMD) (Cascade-2). CAR1 indicates wild type CAR, 













Figure 2. Cofactor regenerating systems used in this work for in vitro bioconversion of 
adipic acid (AA) to 6-aminocaproic acid (6-ACA) and 1,6-hexamethylenediamine 
(HMD) using CARs and ωTAs. Ala-DH, alanine dehydrogenase; FDHwt, wild type 
formate dehydrogenase; FDH mutant, D222Q/H224N mutant formate dehydrogenase; 
Glu-DH, glutamate dehydrogenase; polyP, polyphosphate; PPK2, polyphosphate kinase 











Figure 3. In vitro biotransformation of adipic acid (AA) and 6-aminocaproic acid (6-
ACA) using wild type MAB4714 and ωTAs. Reaction mixtures contained 10 mM 
substrate (AA or 6-ACA), regenerating systems (see Materials and Methods), 80 µg of 












Figure 4. Crystal structure of the MCH22995 A-domain in complex with AMP and 
succinic acid. (A), Overall fold of the A-domain (1-641 aa) showing two views related by 
90° rotation. The protein is shown as a ribbon diagram with the core sub-domain colored 
wheat and C-terminal sub-domain colored cyan. The protein termini are designated as N 
and C. (B), The A-domain structure showing the position of two ligands bound in the 
	 32	
active site. Protein ribbon diagram is colored as in A, whereas the ligands are shown as 
sticks with carbons colored yellow (AMP) and cyan (succinate). (C) Close-up view of the 
A domain active site with bound AMP and succinate. The ligand molecules are shown as 
stick models with yellow (AMP) or cyan (succinic acid) carbons, whereas side chains of 
the active site are shown as sticks with brown carbons. (D), Structural superimposition of 
the A-domains of MCH22995 (PDB code 6OZ1) and MAB4714 showing the equivalent 
residues in their active sites (generated using Phyre2). The right panel presents a zoomed 
in image of the substrate binding pocket. Electron densities shown for AMP and 
succinate are a simulated annealing Fo-Fc map contoured at 2.0 σ, generated with 
coordinates for AMP and succinate omitted. Dashed lines indicate hydrogen bonds or 
electrostatic interactions. Residues are labeled in brown for MCH22995 and black for 
MAB4714. L345/L342 (which is targeted for mutagenesis) is italicized, and its distance 



























Figure 5. Carboxylate binding pocket of CAR (MCH22995) and substrate profiles of 
purified mutant proteins (MAB4714). A close-up view of substrate binding pockets: (A), 
wild type protein; (B, C, D), mutant proteins with Leu345 mutated to Glu (B), or Gly421 
mutated to Glu (C), or Ala429 mutated to Trp (D) (energy minimized models generated 
using YASARA). Protein ribbon diagrams are colored gray with side chains shown as 
sticks with green (wild type) or cyan (mutants) carbons. The bound succinic acid (SA) 
and AMP are shown as stick models with yellow (SA) or magenta (AMP) carbons. (D), 
Carboxylate reductase activities of purified MAB4714 mutant proteins: substrate profiles. 
The corresponding MCH22995 residues presented in panels A-D are shown above the 
mutated residues of MAB4714. The heat map represents CAR activities of purified 
proteins (U/mg) with indicated organic acids. The color code is shown at the bottom 
(with white color indicating no detectable activity). The heat map was generated using 

























Figure 6. In vitro biotransformation of adipic acid (AA) and 6-aminocaproic acid (6-
ACA) by purified wild type and mutant MAB4714 and ω-transaminases (ωTAs). 
Reaction mixtures (200 µl) contained 100 mM HEPES-K buffer (pH 7.5), 10 mM 
substrate (AA or 6-ACA), 2 mM NADPH, cofactor regeneration systems (2 mM ATP, 5 
mM polyP, 10 mM MgCl2, 0.05 mM PLP, 100 mM Na-formate, 50 mM NH4Cl, 2 mM L-
Glu, 20 µg of PPK2/CHU0107, 20 µg of the FDH D222Q/H224N protein, 20 µg of Glu-
DH, and 20 µg of PPA), ωTAs (20 µg of SAV2585 or PatA), and 80 µg of purified wild 
type MAB4714 (WT) or L342E mutant protein (L342E) (overnight incubation at 30°C). 
Reaction products (6-ACA and 1,6-HMD) were analyzed using HPLC (C18 column) 
after O-phthalaldehyde derivatization of amine groups as described in Materials and 
Methods.  
	
	
	
	
	
	
	
	
